Corona News Bulletins

Singapore's latest Covid spike may be peaking, but don't stop vaccinating, health minister says

December 20, 2023

Singapore's health minister has urged the public to continue receiving Covid vaccinations as cases in the city state remain high. from...

Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma

December 20, 2023

Wall Street turned its focus to a handful of newer treatments in different disease areas in 2023, including weight loss medications and a ne...

SEC charges ex-CEO of medical device company with fraud, says some devices were 'just a piece of plastic'

December 19, 2023

The SEC on Tuesday charged former Stimwave Technologies CEO with allegedly defrauding investors out of $41 million. from Health and Scienc...

Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips

December 19, 2023

Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club's Monthly ...

The weight loss drug boom isn't over yet — here's what to expect in the year ahead

December 17, 2023

2024 will be another big year for weight loss drugs, which soared in popularity despite hefty price tags, mixed insurance coverage and unple...

Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook

December 15, 2023

The launch of Eli Lilly's weight-loss drug Zepbound is going swimmingly in the U.S., Jefferies said Friday. from Health and Science ht...

Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says

December 14, 2023

Those results build on midstage trial data Moderna and Merck released earlier this year, which examined the efficacy of the combination over...

Vertex shares pop after nonopioid painkiller posts positive midstage trial results

December 13, 2023

The results support Vertex's hopes of developing a drug that can provide strong pain relief without the addictive potential of opioid me...

Google is rolling out new AI models for health care. Here's how doctors are using them

December 13, 2023

Google announces MedLM, a new suite of health-care specific AI models. from Health and Science https://ift.tt/nyMYvCf https://ift.tt/OYkr...

Weight gain after stopping Eli Lilly's new obesity treatment should help, not hurt the stock

December 12, 2023

Data showing weight gain after stopping Eli Lilly's Zepbound was positive despite earlier selling pressure, Jim Cramer said Tuesday. f...

Patients regain weight after stopping Eli Lilly's Zepbound, study says

December 11, 2023

The data suggests that people have to stay on the weekly injection Zepbound if they want to maintain weight loss. from Health and Science ...

Flying solo without Cigna will keep Humana focused on 2 big priorities in the year ahead

December 11, 2023

Humana can now work to keep up its strong performance in Medicare Advantage and execute on a smooth CEO transition. from Health and Scienc...

Fraud in a bottle: How Big Pharma takes on criminals who make millions off counterfeit drugs

December 11, 2023

A CNBC investigation found criminal networks altering pill bottles of lifesaving drugs and then selling them back to pharmacies at large dis...

U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease

December 08, 2023

Casgevy uses Nobel Prize-winning technology CRISPR to treat sickle cell disease, a blood disorder that affects about 100,000 Americans. fr...

U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients

December 07, 2023

The U.S. Food and Drug Administration is expected to approve exa-cel for sickle cell disease in what would become the first marketed medicin...

Biden administration asserts power to seize drug patents in move to slash high prices

December 07, 2023

The Biden administration unveiled a new framework outlining the factors federal agencies should consider in determining whether to use march...

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

December 06, 2023

The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition....

Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages

December 05, 2023

Eli Lilly's drug serves as an alternative to rival obesity drugs such as Wegovy that are still facing supply issues. from Health and ...

CVS to change how it prices prescription drugs with new pharmacy reimbursement model

December 05, 2023

CVS's new effort aims to do away with a complex model that typically determines how much pharmacies get reimbursed and how much patients...

Reproductive startup launches test to identify an embryo's genetic defects before an IVF pregnancy begins

December 05, 2023

Orchid announces world's first whole genome sequencing report for embryos. from Health and Science https://ift.tt/G8ybsiJ https://ift...

Free ChatGPT may incorrectly answer drug questions, study says

December 04, 2023

The study shows that patients and health-care workers should be cautious about relying on OpenAI's viral chatbot for drug information, t...

Roche enters obesity market with Carmot takeover but drugs may not be available until 2030

December 04, 2023

Roche is to acquire anti obesity drug developer Carmot Therapeutics, becoming the latest pharma company to enter the global weight-loss drug...

Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops

December 02, 2023

Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures da...

Why Pfizer's latest stumble in the obesity market is a boon for Eli Lilly

December 01, 2023

Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that's good news for Club holding Eli Lilly...

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

December 01, 2023

Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in the fir...

Subscribe to: Posts ( Atom )

Corona News Bulletins

Singapore's latest Covid spike may be peaking, but don't stop vaccinating, health minister says

Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma

SEC charges ex-CEO of medical device company with fraud, says some devices were 'just a piece of plastic'

Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips

The weight loss drug boom isn't over yet — here's what to expect in the year ahead

Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook

Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says

Vertex shares pop after nonopioid painkiller posts positive midstage trial results

Google is rolling out new AI models for health care. Here's how doctors are using them

Weight gain after stopping Eli Lilly's new obesity treatment should help, not hurt the stock

Patients regain weight after stopping Eli Lilly's Zepbound, study says

Flying solo without Cigna will keep Humana focused on 2 big priorities in the year ahead

Fraud in a bottle: How Big Pharma takes on criminals who make millions off counterfeit drugs

U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease

U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients

Biden administration asserts power to seize drug patents in move to slash high prices

AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion

Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages

CVS to change how it prices prescription drugs with new pharmacy reimbursement model

Reproductive startup launches test to identify an embryo's genetic defects before an IVF pregnancy begins

Free ChatGPT may incorrectly answer drug questions, study says

Roche enters obesity market with Carmot takeover but drugs may not be available until 2030

Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops

Why Pfizer's latest stumble in the obesity market is a boon for Eli Lilly

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

Random Posts

Popular Posts

Tags

Blog Archive

Labels

Slider Post

Recent Posts

Random Posts

Popular Posts